Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Amgen Inc. Stock Price (Quote) NASDAQ:AMGN
$235.36 ( 1.95% ) Friday, 14th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $213.12 | $235.80 | Friday, 14th Jan 2022 AMGN stock ended at $235.36. This is 1.95% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 2.53% from a day low at $229.99 to a day high of $235.80. |
| 90 days | $198.64 | $235.80 | |
| 52 weeks | $198.64 | $276.69 |
Historical Amgen Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-14 | $230.69 | $235.80 | $229.99 | $235.36 | 2 993 531 |
| 2022-01-13 | $232.05 | $233.23 | $230.33 | $230.85 | 2 153 095 |
| 2022-01-12 | $232.38 | $232.61 | $228.52 | $231.76 | 1 885 896 |
| 2022-01-11 | $230.47 | $232.51 | $228.11 | $232.38 | 2 316 357 |
| 2022-01-10 | $229.25 | $230.64 | $226.00 | $230.37 | 3 191 860 |
| 2022-01-07 | $223.54 | $228.19 | $223.54 | $227.29 | 2 343 065 |
| 2022-01-06 | $225.14 | $226.66 | $223.69 | $225.17 | 2 198 300 |
| 2022-01-05 | $227.04 | $229.87 | $224.52 | $225.14 | 2 783 220 |
| 2022-01-04 | $225.76 | $228.80 | $224.25 | $227.84 | 2 298 317 |
| 2022-01-03 | $223.63 | $226.97 | $222.03 | $226.69 | 2 529 542 |
| 2021-12-31 | $226.26 | $227.74 | $224.80 | $224.97 | 1 529 848 |
| 2021-12-30 | $227.60 | $229.55 | $226.14 | $226.47 | 1 506 524 |
| 2021-12-29 | $225.58 | $228.21 | $224.99 | $227.60 | 1 387 664 |
| 2021-12-28 | $225.17 | $226.98 | $225.05 | $225.77 | 1 245 677 |
| 2021-12-27 | $223.81 | $225.46 | $222.67 | $225.17 | 1 739 265 |
| 2021-12-23 | $222.37 | $224.48 | $221.50 | $223.79 | 1 668 828 |
| 2021-12-22 | $220.00 | $221.90 | $217.76 | $221.53 | 2 677 734 |
| 2021-12-21 | $220.55 | $223.25 | $219.96 | $220.92 | 2 987 556 |
| 2021-12-20 | $222.25 | $222.49 | $218.69 | $219.99 | 2 922 319 |
| 2021-12-17 | $222.69 | $224.16 | $219.32 | $222.50 | 6 428 600 |
| 2021-12-16 | $220.00 | $231.04 | $220.00 | $222.58 | 6 027 165 |
| 2021-12-15 | $214.00 | $219.50 | $213.12 | $219.25 | 3 924 692 |
| 2021-12-14 | $211.32 | $214.81 | $210.23 | $213.74 | 2 602 558 |
| 2021-12-13 | $210.43 | $213.19 | $209.00 | $211.39 | 2 721 280 |
| 2021-12-10 | $213.30 | $214.45 | $210.01 | $210.89 | 2 812 179 |
| 2021-12-09 | $213.53 | $213.98 | $209.50 | $212.57 | 2 699 809 |
| 2021-12-08 | $212.89 | $213.91 | $210.43 | $213.53 | 2 624 393 |
| 2021-12-07 | $209.15 | $212.44 | $207.36 | $211.32 | 3 309 538 |
| 2021-12-06 | $206.38 | $211.79 | $205.97 | $208.79 | 3 998 627 |
| 2021-12-03 | $201.38 | $203.80 | $200.84 | $202.44 | 3 591 874 |
| 2021-12-02 | $200.73 | $203.10 | $199.31 | $201.17 | 2 858 152 |
| 2021-12-01 | $200.44 | $205.64 | $198.64 | $200.80 | 3 058 566 |
| 2021-11-30 | $202.73 | $203.87 | $198.73 | $198.88 | 5 374 002 |
| 2021-11-29 | $202.48 | $204.83 | $201.59 | $203.47 | 2 516 502 |
| 2021-11-26 | $204.74 | $206.00 | $200.52 | $201.09 | 3 116 688 |
| 2021-11-24 | $204.30 | $205.28 | $202.95 | $203.97 | 1 698 912 |
| 2021-11-23 | $202.23 | $205.48 | $201.27 | $204.53 | 2 149 234 |
| 2021-11-22 | $205.45 | $206.30 | $200.75 | $202.73 | 2 824 399 |
| 2021-11-19 | $205.27 | $206.20 | $203.67 | $206.08 | 3 216 370 |
| 2021-11-18 | $205.63 | $206.23 | $203.73 | $204.02 | 4 258 718 |
| 2021-11-17 | $205.21 | $207.35 | $203.60 | $205.82 | 3 321 437 |
| 2021-11-16 | $208.03 | $209.04 | $205.27 | $205.39 | 2 790 894 |
| 2021-11-15 | $210.69 | $210.89 | $207.08 | $207.40 | 3 129 183 |
| 2021-11-12 | $210.51 | $211.08 | $208.61 | $209.61 | 4 592 446 |
| 2021-11-11 | $212.28 | $212.28 | $208.79 | $209.78 | 2 615 911 |
| 2021-11-10 | $211.49 | $213.69 | $210.74 | $211.42 | 2 360 598 |
| 2021-11-09 | $209.24 | $211.90 | $208.70 | $209.93 | 2 296 256 |
| 2021-11-08 | $214.06 | $214.44 | $210.93 | $211.37 | 2 519 954 |
| 2021-11-05 | $215.61 | $217.42 | $212.73 | $213.77 | 2 258 629 |
| 2021-11-04 | $218.30 | $218.45 | $211.72 | $214.93 | 2 772 409 |
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The companys principal products include Neulasta, a pegylated protein to decrease the incidence of infection associated with chemotherapy-induced febrile neutropenia in cancer patients; NEUPOGEN, a rec... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
